Translating new therapeutics and diagnostics for major pregnancy complications

转化主要妊娠并发症的新疗法和诊断方法

• 批准号: nhmrc : GNT1136418
• 负责人: Prof Stephen Tong
• 金额: $ 48.12万
• 依托单位国家: 澳大利亚
• 项目类别: Practitioner Fellowships
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/translating-new-therapeutics-pregnancy-complications/1348050
• 关键词: Translating; new; therapeutics; diagnostics; major

My research is focussed on tackling major complications of pregnancy that are a threat to the lives of both mother’s and babies. We are developing new drug treatments for ectopic pregnancy (a dangerous condition where the pregnancy implants in the Fallopian tube), and preeclampsia (a condition where toxins leak out of the placenta into mum's blood, and can seriously injure many of mum's major organs). We are also generating a blood test that may help women avoid the tragedy of a stillbirth.

我的研究重点是解决对母亲和婴儿生命构成威胁的主要妊娠并发症。我们正在开发新的药物治疗异位妊娠（一种危险的情况，怀孕植入输卵管）和先兆子痫（一种毒素从胎盘泄漏到妈妈血液中的情况，并可能严重伤害妈妈的许多主要器官）。我们还正在开发一种血液检测方法，可以帮助妇女避免死产的悲剧。